- Home
- NMG vs BVS Comparison
NMG vs BVS Comparison
Compare NMG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- BVS
- Stock Information
- Founded
- NMG 2011
- BVS 2011
- Country
- NMG Canada
- BVS United States
- Employees
- NMG N/A
- BVS N/A
- Industry
- NMG Other Metals and Minerals
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NMG Basic Materials
- BVS Health Care
- Exchange
- NMG Nasdaq
- BVS Nasdaq
- Market Cap
- NMG 448.1M
- BVS 476.3M
- IPO Year
- NMG 2017
- BVS 2021
- Fundamental
- Price
- NMG $2.45
- BVS $7.55
- Analyst Decision
- NMG Strong Buy
- BVS Strong Buy
- Analyst Count
- NMG 3
- BVS 4
- Target Price
- NMG $4.22
- BVS $13.75
- AVG Volume (30 Days)
- NMG 1.9M
- BVS 260.7K
- Earning Date
- NMG 11-14-2025
- BVS 11-04-2025
- Dividend Yield
- NMG N/A
- BVS N/A
- EPS Growth
- NMG N/A
- BVS N/A
- EPS
- NMG N/A
- BVS 0.15
- Revenue
- NMG N/A
- BVS $563,829,000.00
- Revenue This Year
- NMG N/A
- BVS N/A
- Revenue Next Year
- NMG N/A
- BVS $7.22
- P/E Ratio
- NMG N/A
- BVS $49.16
- Revenue Growth
- NMG N/A
- BVS 1.58
- 52 Week Low
- NMG $1.22
- BVS $5.81
- 52 Week High
- NMG $6.06
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- NMG 41.82
- BVS 63.15
- Support Level
- NMG $2.75
- BVS $6.50
- Resistance Level
- NMG $3.60
- BVS $7.15
- Average True Range (ATR)
- NMG 0.42
- BVS 0.33
- MACD
- NMG -0.12
- BVS 0.03
- Stochastic Oscillator
- NMG 8.36
- BVS 60.69
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.